cbdMD, Inc.

NYSEAM:YCBD Stock Report

Market Cap: US$8.5m

cbdMD Management

Management criteria checks 3/4

cbdMD's CEO is T. Kennedy, appointed in Oct 2020, has a tenure of 5.58 years. total yearly compensation is $300.00K, comprised of 91.7% salary and 8.3% bonuses, including company stock and options. directly owns 0.65% of the company’s shares, worth $55.69K. The average tenure of the management team and the board of directors is 5.6 years and 3.8 years respectively.

Key information

T. Kennedy

Chief executive officer

US$300.0k

Total compensation

CEO salary percentage91.67%
CEO tenure5.6yrs
CEO ownership0.7%
Management average tenure5.6yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

Analysis Article Mar 23

cbdMD (NYSEMKT:YCBD) Has Debt But No Earnings; Should You Worry?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article Feb 23

This Insider Has Just Sold Shares In cbdMD, Inc. (NYSEMKT:YCBD)

Some cbdMD, Inc. ( NYSEMKT:YCBD ) shareholders may be a little concerned to see that the Chairman & Co-CEO, Martin...
Analysis Article Feb 09

If You Had Bought cbdMD (NYSEMKT:YCBD) Stock A Year Ago, You Could Pocket A 383% Gain Today

While some are satisfied with an index fund, active investors aim to find truly magnificent investments on the stock...
Analysis Article Jan 13

We Wouldn't Rely On cbdMD's (NYSEMKT:YCBD) Statutory Earnings As A Guide

It might be old fashioned, but we really like to invest in companies that make a profit, each and every year. However...
Analysis Article Dec 15

Is cbdMD (NYSEMKT:YCBD) Using Debt Sensibly?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

CEO Compensation Analysis

How has T. Kennedy's remuneration changed compared to cbdMD's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2025n/an/a

-US$4m

Sep 30 2025US$300kUS$275k

-US$4m

Jun 30 2025n/an/a

-US$5m

Mar 31 2025n/an/a

-US$4m

Dec 31 2024n/an/a

-US$7m

Sep 30 2024US$275kUS$275k

-US$8m

Jun 30 2024n/an/a

-US$23m

Mar 31 2024n/an/a

-US$26m

Dec 31 2023n/an/a

-US$24m

Sep 30 2023US$275kUS$275k

-US$27m

Jun 30 2023n/an/a

-US$26m

Mar 31 2023n/an/a

-US$56m

Dec 31 2022n/an/a

-US$59m

Sep 30 2022US$558kUS$276k

-US$74m

Jun 30 2022n/an/a

-US$63m

Mar 31 2022n/an/a

-US$29m

Dec 31 2021n/an/a

-US$37m

Sep 30 2021US$720kUS$247k

-US$26m

Compensation vs Market: T.'s total compensation ($USD300.00K) is below average for companies of similar size in the US market ($USD627.70K).

Compensation vs Earnings: T.'s compensation has increased whilst the company is unprofitable.


CEO

T. Kennedy (45 yo)

5.6yrs
Tenure
US$300,000
Compensation

Mr. T. Ronan Kennedy has been the Chief Financial Officer at cbdMD, Inc., since October 1, 2020 and serves as its Chief Executive Officer since Oct 2025 and was Interim Chief Executive Officer and Principa...


Leadership Team

NamePositionTenureCompensationOwnership
T. Kennedy
CEO, CFO5.6yrsUS$300.00k0.65%
$ 55.7k
Bradley Whitford
Chief Accounting Officer2.2yrsUS$207.31k0.00053%
$ 45.1
Sibyl Swift
CSO, VP of Regulatory Affairs & Directorno dataUS$115.06k0.025%
$ 2.1k
Zeb Booker
Chief Technology Officer7.3yrsno datano data
Lance Blundell
General Counsel7.4yrsno datano data
Francisco Mangual
Senior VP of Sales7.5yrsno datano data
Shannon Charles
Chief Marketing Officer3.3yrsno datano data
David Johnson
Senior VP of Business Development4.4yrsno datano data
5.6yrs
Average Tenure
45.5yo
Average Age

Experienced Management: YCBD's management team is seasoned and experienced (5.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
T. Kennedy
CEO, CFO1.4yrsUS$300.00k0.65%
$ 55.7k
Sibyl Swift
CSO, VP of Regulatory Affairs & Director3.8yrsUS$115.06k0.025%
$ 2.1k
Jeffrey Porter
Independent Director1.1yrsUS$20.79k1.04%
$ 88.4k
Scott Stephen
Independent Chairman7.1yrsUS$71.12k0.027%
$ 2.3k
William Raines
Independent Director7.1yrsUS$57.20k0.12%
$ 9.8k
Bakari Sellers
Independent Director9.2yrsUS$47.52k0.026%
$ 2.2k
Kevin Roe
Independent Director1.1yrsUS$23.01k0.24%
$ 20.4k
3.8yrs
Average Tenure
52yo
Average Age

Experienced Board: YCBD's board of directors are considered experienced (3.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/15 07:07
End of Day Share Price 2026/05/15 00:00
Earnings2026/03/31
Annual Earnings2025/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

cbdMD, Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael HickeyBenchmark Company
William SutherlandBenchmark Company
Anthony VendettiMaxim Group